New risks inadequately managed: the case of smart implants and medical device regulation

ABSTRACT Many emerging technologies are associated with ‘risk’. While the concept of risk is protean, it is usually conceived of as the potential of something damaging or harmful happening. Thus, risks are a primary target of many regulatory regimes. In this article, after articulating an understanding of risk, we assess the European medical devices regulatory regime from a risk perspective, focusing on its handling of ‘smart’ implantable medical devices. In doing so, we discuss the empirical evidence obtained from expert participants in the Implantable Smart Technologies Project, which evidence is framed around three risk typologies: materiality, geography and modality. We conclude that none of these risks are sufficiently addressed within the existing regime, which falls down not just from a standards perspective, but also from the perspective of transparency and balance.

[1]  Christa Altenstetter,et al.  Medical Device Regulation and Nanotechnologies: Determining the Role of Patient Safety Concerns in Policymaking , 2011 .

[2]  A. Peñaranda,et al.  Parents' narratives on cochlear implantation: reconstructing the experience of having a child with cochlear implant , 2011, Cochlear implants international.

[3]  R. Mackenzie.  Who Should Hold the Remote for the New Me? Cognitive, Affective, and Behavioral Side Effects of DBS and Authentic Choices Over Future Personalities , 2011 .

[4]  Aaron S Kesselheim,et al.  Regulation of medical devices in the United States and European Union. , 2012, The New England journal of medicine.

[5]  B P Tucker,et al.  Deaf culture, cochlear implants, and elective disability. , 1998, The Hastings Center report.

[6]  Y. Hu.  A Risk Society , 2013, Rural Health Care Delivery.

[7]  Tadayoshi Kohno,et al.  A Review of the Security of Insulin Pump Infusion Systems , 2011, Journal of diabetes science and technology.

[8]  W. Maisel,et al.  Semper fidelis--consumer protection for patients with implanted medical devices. , 2008, The New England journal of medicine.

[9]  Kevin Fu,et al.  Trustworthy Medical Device Software , 2011 .

[10]  C. Vassy,et al.  From a genetic innovation to mass health programmes: the diffusion of Down's Syndrome prenatal screening and diagnostic techniques in France. , 2006, Social science & medicine.

[11]  Joseph Michael Valente.  Cyborgization: Deaf Education for Young Children in the Cochlear Implantation Era , 2011 .

[12]  T. Kohno,et al.  Improving the security and privacy of implantable medical devices. , 2010, The New England journal of medicine.

[13]  Elettra Ronchi,et al.  Evidence, politics, and technological change. , 2005, Health affairs.

[14]  Pim Haselager,et al.  Did My Brain Implant Make Me Do It? Questions Raised by DBS Regarding Psychological Continuity, Responsibility for Action and Mental Competence , 2010, Neuroethics.

[15]  McGinnis Jm,et al.  The learning healthcare system : workshop summary , 2007 .

[16]  Ortwin Renn.  Three decades of risk research: accomplishments and new challenges , 1998 .

[17]  World Medical Association (WMA),et al.  Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.

[18]  Fotios Papadimitrakopoulos,et al.  A Review of the Biocompatibility of Implantable Devices: Current Challenges to Overcome Foreign Body Response , 2008, Journal of diabetes science and technology.

[19]  Non-use of cochlear implants in children: child and parent perspectives , 2005 .

[20]  W. Glannon.  Consent to Deep Brain Stimulation for Neurological and Psychiatric Disorders , 2010, The Journal of Clinical Ethics.

[21]  Yao Yao,et al.  Ensuring the Safety of Marketed Medical Devices CDRH's Medical Device Postmarket Safety Program(1) , 2008 .

[22]  Mitchell D. Feldman,et al.  Who is Responsible for Evaluating the Safety and Effectiveness of Medical Devices? The Role of Independent Technology Assessment , 2007, Journal of General Internal Medicine.

[23]  Kevin Fu,et al.  Security and Privacy for Implantable Medical Devices , 2008, IEEE Pervasive Comput..

[24]  G. Thomas,et al.  Reinventing grounded theory: some questions about theory, ground and discovery , 2006 .

[25]  Deborah Cohen,et al.  Europeans are left to their own devices , 2011, BMJ : British Medical Journal.

[26]  S S Blume,et al.  Histories of cochlear implantation. , 1999, Social science & medicine.

[27]  M Billingsley,et al.  Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts , 2011, BMJ Open.

[28]  Kevin Fu,et al.  Security and Privacy Qualities of Medical Devices: An Analysis of FDA Postmarket Surveillance , 2012, PloS one.

[29]  Robert James Sparrow,et al.  Defending Deaf Culture: The Case of Cochlear Implants* , 2005 .

[30]  Frederic S. Resnic,et al.  Postmarketing surveillance of medical devices--filling in the gaps. , 2012, The New England journal of medicine.

[31]  Gill Haddow,et al.  Cyborgs in the Everyday: Masculinity and Biosensing Prostate Cancer , 2015, Science as culture.

[32]  Gill Haddow,et al.  Implantable Smart Technologies (IST): Defining the ‘Sting’ in Data and Device , 2015, Health Care Analysis.

[33]  M. Okun,et al.  Identifying candidates for deep brain stimulation in Parkinson's disease: the role of the primary care physician. , 2007, Geriatrics.

[34]  M. Cheng.  An overview of medical device policy and regulation , 2007 .

[35]  Robertas Blaudžiūnas.  Notes for Contributors , 2016 .

[36]  Anselm L. Strauss,et al.  Basics of qualitative research : techniques and procedures for developing grounded theory , 1998 .

[37]  N. Hoffart.  Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory , 2000 .

[38]  E. Gisquet.  Cerebral implants and Parkinson's disease: a unique form of biographical disruption? , 2008, Social science & medicine.

[39]  Lawton R. Burns,et al.  The business of healthcare innovation , 2005 .

[40]  Nicolas Pallikarakis,et al.  Analysis and Classification of Medical Device Recalls , 2007 .

[41]  Y. Bazin.  The Politics of Global Regulation , 2010 .

[42]  Deborah Cohen,et al.  How a fake hip showed up failings in European device regulation , 2012, BMJ : British Medical Journal.

[43]  Matthew Thompson,et al.  Medical device recalls and transparency in the UK , 2011, BMJ : British Medical Journal.

[44]  Fotios Papadimitrakopoulos,et al.  Biomaterials/Tissue Interactions: Possible Solutions to Overcome Foreign Body Response , 2010, The AAPS Journal.